Menna Fouda, MD, The Royal Wolverhampton NHS Trust, Wolverhampton, UK, discusses the impact of the COVID-19 pandemic on treatment access for patients with breast cancer in the UK. Dr Fouda notes that patients receiving chemotherapy were the most affected, with guidelines recommending schedule modifications for reduced hospital visits. Telemedicine was also broadly implemented which has had positive impacts. This interview took place during the 17th St. Gallen International Breast Cancer Conference.

свернуть